RMS, RMS. (rhabdomyosarcoma,rms) (Intergroup RMS Study Group,IRSG) ( European Pediatric soft tissue sarcomas study group,epssg)
|
|
- Loren Hill
- 5 years ago
- Views:
Transcription
1 Chin J Pediatr, October 2017, Vol.55, No.10 ( CCCG-RMS-2016) (rhabdomyosarcoma,rms), 6.5% [1-3], RMS,, (Intergroup RMS Study Group,IRSG) ( European Pediatric soft tissue sarcomas study group,epssg) 20,, RMS 3,,,, RMS [1,4-6] ,(Chinese Children Cancer Group, CCCG), RMS 5 RMS, [7] :,,, IRSG EpSSG [4-6,8-14], < DOI: /cma.j.issn : ( ) ; ( Z ) :,100045, mxl1123@vip.sina.com 1. : 2. : B (MRI) CT CT, (PET-CT) 3. : 4. :,,,( ) 5.:,, (WHO) RMS : 1. (ERMS):, (ARMS): ARMS t(2;13)(q35;q14) t(1;13)(q36;q14) PAX3-FKHR PAX7-FKHR,PAX3-FKHR 3. ( pleomorphic or anaplastic RMS):, ( 1) (IRS) -( 2),
2 Chin J Pediatr, October 2017, Vol.55, No TNM ( cm) 1 a T 1 T 2 5 >5 N 0 N 1 N X M 0 2 b T 1 T 2 5 N 0 N X M 0 3 T 1 T 2 5 >5 N 1 N 0 N 1 N X M 0 4 T 1 T 2 5 >5 N 0 N 1 M 1 : a ( ) ; b, ;T 1 : ;T 2 :, ; N 0 :;N 1 :;N x : ; M 0 : ;M 1 : - Ⅰ Ⅱ Ⅲ Ⅳ,,,(, ) Ⅰa Ⅰb,, a b Ⅱa,, Ⅱb,, Ⅱc,,, Ⅲa Ⅲb, c, (, ) : a ; b ; c TNM, ( 3), TNM IRS 1 Ⅰ ~Ⅲ 2 ~3 Ⅰ ~Ⅱ 2 ~3 Ⅲ 1 ~3 Ⅰ ~Ⅲ 4 Ⅳ a 3 ~4 Ⅲ ~Ⅳ :IRS: ; a 1. :,,,,, ( ) 3 ~6 (4 ~8 ),, 2. :RMS IRS-Ⅰ,Ⅱ ~ Ⅳ, Ⅰ TNM 1, 50.4 Gy,, RMS 4 :,, (Gy) IRS-Ⅰ 0 IRS-Ⅰ 36.0 IRS-Ⅱa 36.0 IRS-Ⅱb Ⅱc ( ) 41.4 IRS-Ⅲ( ) 45.0 IRS-Ⅲ( ) :IRS:
3 Chin J Pediatr, October 2017, Vol.55, No.10 1 ;,,,,, 13, 25, 3. : :(1), ;,, 7 d 1, PAX3-FKHR PAX7-FKHR, (2) D( ACTD) (ADR), (3), ( 5 ~8) 2.0 mg,actd 2.5 mg 4 ~6, 12 12, (4): <12 12 kg, = /30 ( kg), 21 d (ANC) > /L, (PLT) > /L 24 ~48 h, 0 0 B CT 4 2 VAC B 10 4 VAC B CT VA VA B 19 7 VA VA - :VAC: + D +;VA: + D; MRI: ; VAC VA : : 1.5 mg /m 2, d1 d8 d15, D:0.045 mg /( kg ) + 5 min,d1,:1.2 g /m 2 1 h,d1[ h mg /( m 2 ) + 20 ~30 min] ; <12, D ; 4, 4, 10 ; B CT ; B CT 4 2 VAC VI B 10 4 VAC VI B VAC 19 6 VAC VI B 22 7 VAC VAC VI B 28 9 VAC VAC VI B VAC VAC VI B VAC - :VAC: + D +;VI: + ;MRI: ;VAC ;VI :, 50 mg /m 2, d1 ~5, 90 min, 100 mg /d,, UGT1A1 ; 42, 4 ~6, 13, 12 ; 12,; B CT ; - ( G-CSF) ( GM- CSF) >28 d 25% (5) : NCI (CTCAE version 4.0,2009) (ALT) < 2, < 1.5 (Ccr) (6) [25 mg / (kg d), 2 /d], 3 d, 3 1. :(1) :, CT B CT 2 : B, RMS,,, CT (2) : B CT CT, (3) 1, (4)
4 Chin J Pediatr, October 2017, Vol.55, No B CT 4 2 VI B 10 4 VI B VDC IE B 22 7 VDC IE B CT 28 9 VAC VI B VDC IE B VDC IE B VAC VI B VDC IE B CT :VAC: + D +;VI: + ;VDC: + +;IE: + ;MRI: ;VAC VI ;VDC IE :, 30 mg /m 2,d1 ~2, 1.2 g /m 2 1 h,d1, 1.8 g /m 2,d1 ~5, 100 mg /m 2,d1 ~5; 54, 12 12,; - (CR) ( PR) (PD), 6 ~8 2. : CR: 4, PR: 64%, 30%, PD: 40%, 20%, ( SD): PD PR 3.:CR: CR, PR: CR, SD, PR: CR, PR SD, PR: PR, CR PR SD, SD: SD, CR PR SD, PD: PD VAI - B CT 4 2 VACa B 7 3 VDE VDI VAI - B CT 16 6 VACa B 19 7 VDE VDI B CT VAI VACa B VDE VDI B VAI VACa B VDE VDI - :VAI: + D + ;VACa: + D + ;VDE: + +;MRI: ;VDI : + + ;VAI :, D:1.5 mg /m 2, d1, :3 g /m 2, d1 ~3[ h mg /( m 2 ) ] ;VACa : D VAI, 560 mg /m 2,d1;VDE :, : 25 mg /m 2, d1 ~2, 150 mg / ( m 2 ), d1 ~3;VDI : +, 3 g /m 2,d1 ~3; 24,,25 ~48 ; 24,, VDC( + +) IE( + ) ; 48, 12, ,;, B CT ; - X 2. 2 ~3 4 X X 4. 5 ~ ( ) ( ) : ( ) ;( ) ;
5 Chin J Pediatr, October 2017, Vol.55, No.10 ( ) ; ( ) ; ( ) ;( ) ; ( ) ; ( ) ; ( ) ; ( ) ; ( ) ; ( ) ;( ) ; ( ) ; ( ) ; ( ) [1] Rudzinski ER, Anderson JR, Hawkins DS, et al.the World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children s Oncology Group [ J].Arch Pathol Lab Med, 2015, 139 ( 10 ) : DOI: /arpa oa. [2] PDQ Cancer Information Summaries [ M ]. Bethesda ( MD ) : National Cancer Institute ( US),2002. [3]. [ M]. :, 2001:1-6. [4] Huh W. Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients with Newly Diagnosed Low-Risk Embryonal /Botryoid /Spindle Cell Rhabdomyosarcoma [ EB /OL ]. ( ) [ [5] Huh W. Intensive Multi-Agent Therapy, Including Dose- Compressed Cycles of Ifosfamide /Etoposide ( IE) and Vincristine / Doxorubicin /Cyclophosphamide ( VDC ) for Patients with High- Risk Rhabdomyosarcoma [ EB /OL ]. ( ) [ [6] Huh W. Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide ( VAC ) versus VAC Alternating with Vincristine and Irinotecan ( VI) for Patients with Intermediate- Risk Rhabdomyosarcoma [ EB /OL ]. ( ) [ [7] Ma X, Huang D, Zhao W, et al.clinical characteristics and prognosis of childhood rhabdomyosarcoma: a ten-year retrospective multicenter study[ J].Int J Clin Exp Med, 2015,8(10) : [8] Walterhouse DO, Pappo AS, Meza JL, et al.shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children s Oncology Group [ J].J Clin Oncol, 2014,32(31) : DOI: / JCO [9] Rosenberg AR, Anderson JR, Lyden E, et al.early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children s Oncology Group[ J].Eur J Cancer, 2014,50(4) : DOI: /j.ejca [10] Weiss AR, Lyden ER, Anderson JR, et al. Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children s Oncology Group Soft Tissue Sarcoma Committee[ J].J Clin Oncol, 2013, 31 ( 26 ) : DOI: /JCO [11] Dharmarajan KV, Wexler LH, Wolden SL.Concurrent radiation with irinotecan and carboplatin in intermediate -and high-risk rhabdomyosarcoma: a report on toxicity and efficacy from a prospective pilot phase II study[ J].Pediatr Blood Cancer, 2013, 60(2) : DOI: /pbc [12] Wolden SL, Lyden ER, Arndt CA, et al. Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children s Oncology Group[ J].Int J Radiat Oncol Biol Phys, 2015,93 ( 5 ) : DOI: /j.ijrobp [13] Weigel BJ, Lyden E, Anderson JR, et al.intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide / Etoposide and Vincristine /Doxorubicin /Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children s Oncology Group[ J].J Clin Oncol, 2016, 34 ( 2 ) : DOI: /JCO [14] Ben AM, Minard-Colin V, Mosseri V, et al.does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma? [ J ]. Eur J Cancer, 2015, 51 (2) : DOI: /j.ejca ( : ) (: ),,, 1. : ( ( 2. :, 3.:,, ;,
Kavita V. Dharmarajan, MD, MSc, 1 * Leonard H. Wexler, MD, 2 and Suzanne L. Wolden, MD 1 INTRODUCTION. Pediatr Blood Cancer 2013;60:
Pediatr Blood Cancer 2013;60:242 247 Concurrent Radiation With Irinotecan and Carboplatin in Intermediate- and High-Risk Rhabdomyosarcoma: A Report on Toxicity and Efficacy From a Prospective Pilot Phase
More informationOriginal Articles. The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma
Original Articles The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma A Report From the Children s Oncology Group Erin R. Rudzinski, MD; James R. Anderson,
More informationEffective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,
Ewing Tumor Perez Ewing tumor is the second most common primary tumor of bone in childhood, and also occurs in soft tissues Ewing tumor is uncommon before 8 years of age and after 25 years of age In the
More informationIJC International Journal of Cancer
IJC International Journal of Cancer Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: A report from the Children s Oncology Group Soft Tissue
More informationConsensus and controversies regarding the treatment of rhabdomyosarcoma
Received: 16 June 2017 Revised: 28 July 2017 Accepted: 10 August 2017 DOI: 10.1002/pbc.26809 REVIEW Pediatric Blood & Cancer The American Society of Pediatric Hematology/Oncology Consensus and controversies
More informationCURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of )
Leukemia AALL0932 closed after Induction CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 10.10.2017) Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized
More informationCURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017)
CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017) Leukemia AALL0932 closed after Induction Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized
More informationPediatric bladder/prostate rhabdomyosarcoma: Eight cases from a single center
The Turkish Journal of Pediatrics 2016; 58: 254-258 Original Pediatric bladder/prostate rhabdomyosarcoma: Eight cases from a single center Suna Emir 1, Sonay İncesoy Özdemir 2, Hacı Ahmet Demir 1, Derya
More informationTreatment outcome of rhabdomyosarcoma in Hong Kong Chinese children
Title Treatment outcome of rhabdomyosarcoma in Hong Kong Chinese children Author(s) Yuan, XJ; Chan, GCF; Chan, SK; Shek, TWH; Kwong, DLW; Wei, WI; Ha, SY; Chiang, AKS Citation Hong Kong Medical Journal,
More informationPAX-FOXO1 Fusion Status Drives Unfavorable Outcome for Children With Rhabdomyosarcoma: A Children s Oncology Group Report
Pediatr Blood Cancer 2013;60:1411 1417 PAX-FOXO1 Fusion Status Drives Unfavorable Outcome for Children With Rhabdomyosarcoma: A Children s Oncology Group Report Stephen X. Skapek, MD, 1 * James Anderson,
More informationRhabdomyosarcoma. Disclosures. Abbreviations. COG Disclosure. Abbreviations. Objectives. Progress & Challenges in COG Clinical Trials
1 Disclosures Rhabdomyosarcoma: Progress & Challenges in COG Clinical Trials Amy Newman and Shari Feinberg have no industry relationships relevant to this presentation Off label use will be discussed Shari
More informationRHABDOMYOSARCOMA AT RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL
RHABDOMYOSARCOMA AT RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL 1990-2010. Protocol Revision and Outcome Marc Hendricks 1, Alan Davidson 1, Ann van Eyssen 1, Komala Pillay 2, Alp Numanoglu 3, Alastair Millar
More informationUK Musculoskeletal Oncology: Something for All Ages. Lars Wagner, MD Pediatric Hematology/Oncology University of Kentucky
UK Musculoskeletal Oncology: Something for All Ages Lars Wagner, MD Pediatric Hematology/Oncology University of Kentucky Pediatric-Type Sarcomas of Bone and Soft Tissue The incidence of sarcoma continues
More informationIrinotecan and temozolomide in adults with recurrent sarcoma
ORIGINAL ARTICLE Irinotecan and temozolomide in adults with recurrent sarcoma Phillip S. Blanchette 1, Aaron Lo 2, Pamela Ng 2, Albiruni Razak 3,4, Eitan Amir 4, David Hogg 4, Martin E. Blackstein 3, Abha
More informationLocal Therapy for Ewing Sarcoma: Current Concepts and Opportunities for Improvement
Local Therapy for Ewing Sarcoma: Current Concepts and Opportunities for Improvement Safia K. Ahmed, MD Department of Radiation Oncology Washington University August 25, 2017 2017 MFMER slide-1 Outline
More informationClinical Study Outcome of Rhabdomyosarcoma in First Year of Life: Children s Cancer Hospital Egypt
Sarcoma Volume 2013, Article ID 439213, 7 pages http://dx.doi.org/10.1155/2013/439213 Clinical Study Outcome of Rhabdomyosarcoma in First Year of Life: Children s Cancer Hospital 57357 Egypt Enas El Nadi,
More informationThe treatment of soft tissue tumours (STS)
Soft Tissue Sarcoma Current Management Meriel Jenney, Ken Brown The treatment of soft tissue tumours (STS) in children and adolescents is complex. The commonest STS occurring in childhood is rhabdomyosarcoma
More informationRhabdomyosarcoma (RMS) is a heterogeneous
Survival rate of children with rhabdomyosarcoma and prognostic factors Khadijeh Arjmandi Rafsanjani, Parvaneh Vossough, Ali Bashardoust, Mohammad Faranoush Tehran, Iran 36 Background: Rhabdomyosarcoma
More informationProton beam therapy for a patient with large rhabdomyosarcoma of the body trunk
Takizawa et al. Italian Journal of Pediatrics (2015) 41:90 DOI 10.1186/s13052-015-0200-0 ITALIAN JOURNAL OF PEDIATRICS CASE REPORT Proton beam therapy for a patient with large rhabdomyosarcoma of the body
More informationOutcome for children with metastatic solid tumors over the last four decades
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 Outcome for children with metastatic solid tumors over the last four decades Stephanie M. Perkins Washington
More informationMojca Velikonja Jože Pižem
Mojca Velikonja Jože Pižem An 81-year old woman presented with an exophytic, wart-like skin lesion on her neck that she had observed for one year. Cryotherapy had been applied twice, but proved unsuccessful.
More informationDiagnosis Place of delivery Proforma
STCYPCNG List of chemotherapy regimens Day Localised Unresectable neuroblastoma (CCLG guidelines) Carbo-Etoposide Etoposide CADO Doxorubin, Vincristine Irinotecan, Irinotecan-TMZ temozolomide Localised
More informationDr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More informationState of the Art Radiotherapy for Pediatric Tumors. Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center
State of the Art Radiotherapy for Pediatric Tumors Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center Introduction Progress and success in pediatric oncology Examples of low-tech and high-tech
More informationCase 1. Disclosure. Imaging. Clinical history 5/10/2016. USCAP 2016 Annual Meeting Evening Specialty Conference Bone and Soft tissue Pathology
Disclosure Dr. Agaram has nothing to disclose Case 1 Narsi Agaram, MBBS USCAP 2016 Annual Meeting Evening Specialty Conference Bone and Soft tissue Pathology Clinical history Imaging 1998 A three month
More informationRhabdomyosarcoma in Children and Adolescents: Patterns and Risk Factors of Distant Metastasis
Pediatric Imaging Original Research Kim et al. Distant Metastasis of Rhabdomyosarcoma in Children and Adolescents Pediatric Imaging Original Research Jeong Rye Kim 1 Hee Mang Yoon 1 Kyung-Nam Koh 2 Ah
More informationRadiation and Hodgkin s Disease: A Changing Field. Sravana Chennupati Radiation Oncology PGY-2
Radiation and Hodgkin s Disease: A Changing Field Sravana Chennupati Radiation Oncology PGY-2 History of Present Illness 19 yo previously healthy male college student began having pain in his R shoulder
More informationRhabdomyosarcoma of the biliary tract: a case report
International Journal of Contemporary Pediatrics Kouadir A et al. Int J Contemp Pediatr. 2017 May;4(3):1093-1097 http://www.ijpediatrics.com pissn 2349-3283 eissn 2349-3291 Case Report DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20171734
More informationSoft-Tissue Sarcomas. Karen H. Albritton Andrea Ferrari. Michela Casanova Introduction
Chapter 11 185 Soft-Tissue Sarcomas Karen H. Albritton Andrea Ferrari. Michela Casanova Contents 11.1 Introduction....................... 185 11.2 Epidemiology/Etiology................ 186 11.3 Biology/Pathology...................
More informationHigh dose chemotherapy in Ewing sarcoma. Nathalie Gaspar Gustave Roussy Cancer Campus, Villejuif (France)
High dose chemotherapy in Ewing sarcoma Nathalie Gaspar Gustave Roussy Cancer Campus, Villejuif (France) Principles of high-dose chemotherapy Log-linear dose/efficacy relation of alkylating agents - Increased
More informationLymph Node Management in Patients With Paratesticular Rhabdomyosarcoma
Original Article Lymph Node Management in Patients With Paratesticular Rhabdomyosarcoma A Population-Based Analysis Nguyen D. Dang, MD 1 ; Phuong-Thanh Dang, BS 2 ; Jason Samuelian, DO 1 ; and Arnold C.
More informationFAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated
Page 1 of 5 COG-AEWS1221: Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly
More informationResearch Article Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma
Sarcoma Volume 2012, Article ID 749067, 4 pages doi:10.1155/2012/749067 Research Article Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma P. Blanchette, 1 D. Hogg, 2 P. Ferguson, 3 J. S.
More informationJAMES EWING, Endothelial origin. 14 yr Girl
JAMES EWING, 1921 Endothelial origin 14 yr Girl SPECTRUM OF ESFT NEURAL DIFFERENTIATION Least Well EWING S SARCOMA ATYPICAL EWING S SARCOMA PNET Peripheral Neuroepithelioma ASKIN TUMOR (thoraco-pulmonary)
More informationUpdate on Sarcomas of the Head and Neck. Kevin Harrington
Update on Sarcomas of the Head and Neck Kevin Harrington Overview Classification and incidence of sarcomas Clinical presentation Challenges to treatment Management approaches Prognostic factors Radiation-induced
More informationPediatric Soft Tissue Sarcomas
C A C a n c e r J C l i n 1 9 9 4 ; 4 4 : 2 1 1-2 4 7 Pediatric Soft Tissue Sarcomas Leonard H. Wexler, MD Lee J. Helman, MD Overview A malignant tumor of mesenchymal cell origin is called a sarcoma. Mesenchymal
More informationClinical Study Desmoid Fibromatosis in Pediatric Patients: Management Based on a Retrospective Analysis of 59 Patients and a Review of the Literature
Sarcoma Volume 2012, Article ID 475202, 9 pages doi:10.1155/2012/475202 Clinical Study Desmoid Fibromatosis in Pediatric Patients: Management Based on a Retrospective Analysis of 59 Patients and a Review
More informationPEDIATRIC. BRAIN ACNS 0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a COMPANION STUDIES
PEDIATRIC BRAIN ACNS 0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in other than Average Risk Medulloblastoma/PNET Patients. https://clinicaltrials.gov/ct2/show/nct00392327?term=0332&rank=6
More informationPrognosis and Outcome of Adult Patients with Ewing Sarcoma (Local Experience)
Journal of Cancer Therapy, 2017, 8, 764-772 http://www.scirp.org/journal/jct ISSN Online: 2151-1942 ISSN Print: 2151-1934 Prognosis and Outcome of Adult Patients with Ewing Sarcoma (Local Experience) Mohamed
More informationPart 1. Slides 1-38, Rita Alaggio Soft tissue tumors Trondheim 14. mars 2013
Part 1 Slides 1-38, Rita Alaggio Soft tissue tumors Trondheim 14. mars 2013 Pediatric Pathology Soft Tissue Tumors AN UPDATE Rita Alaggio Azienda Ospedaliera Università di Padova Soft Tissue Tumors More
More informationTHE OUTCOME OF treatment for children with metastatic
High-Dose Melphalan With Autologous Stem-Cell Rescue in Metastatic Rhabdomyosarcoma By M. Carli, R. Colombatti, O. Oberlin, M. Stevens, L. Masiero, E. Frascella, E. Koscielniak, J. Treuner, and C.R. Pinkerton
More informationBone HDR brachytherapy in a patient with recurrent Ewing s sarcoma of the acetabulum: Alternative to aggressive surgery
Bone HDR brachytherapy in a patient with recurrent Ewing s sarcoma of the acetabulum: Alternative to aggressive surgery Rafael Martínez-Monge 1,* Agata Pérez-Ochoa 1, Mikel San Julián 2, Dámaso Aquerreta
More informationVincristine Ifosfamide Doxorubicin Etoposide (VIDE) Sarcoma
Systemic Anti Cancer Treatment Protocol Vincristine Ifosfamide Doxorubicin Etoposide (VIDE) Sarcoma PROTOCOL REF: MPHAVIDE (Version No: 1.0) Approved for use in: Ewings sarcoma Desmoplastic small round
More informationClinical Management Guideline for Small Cell Lung Cancer
Diagnosis and Staging: Key Points 1. Ensure a CT scan that is
More informationLessons from treatment of pediatric sarcomas at difficult sites. Dr. Andrea Ferrari Pediatric Oncology Unit Istituto Nazionale Tumori, Milan, Italy
Lessons from treatment of pediatric sarcomas at difficult sites Dr. ndrea Ferrari Pediatric Oncology Unit stituto Nazionale Tumori, Milan, taly Disclosure slide have no potential conflicts of interest
More informationAdult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study
Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study JONATHAN NOUJAIM 1, KHIN THWAY 1, ROBIN L. JONES 1, AISHA MIAH 1, KOMEL KHABRA 2, RUPERT LANGER 3, BERND KASPER 4, IAN JUDSON 1, CHARLOTTE
More informationRhabdomyosarcoma Causes, Risk Factors, and Prevention
Rhabdomyosarcoma Causes, Risk Factors, and Prevention Risk Factors and Causes A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors and
More informationJournal of Pediatric Sciences
Journal of Pediatric Sciences Role of post-operative radiation therapy in single brain metastasis from clear cell sarcoma in children: a case report with systemic review Fadoua Rais, Naoual Benhmidou,
More informationWith an annual incidence of 4.3 cases per million persons age 20
2597 Rhabdomyosarcoma in Infants Younger than One Year Old A Report from the Italian Cooperative Group Andrea Ferrari, M.D. 1 Michela Casanova, M.D. 1 Gianni Bisogno, M.D. 2 Ilaria Zanetti, 2 Giovanni
More informationCALGB Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
CALGB 30610 Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer Jeffrey A. Bogart Department of Radiation Oncology Upstate Medical University Syracuse, NY Small Cell Lung Cancer Estimated 33,000
More informationSAALT3W Sarcoma Dr. Meg Knowling. Protocol Code Tumour Group Contact Physician
BCCA Protocol Summary for Etoposide, Ifosfamide-Mesna (SAIME) Alternating with vincristine, DOXOrubicin and Cyclophosphamide (with or without Mesna)(SAVAC or SAVACM) with Filgrastim Support at a THREE
More informationAll India Institute of Medical Sciences, New Delhi, INDIA. Department of Pediatric Surgery, Medical Oncology, and Radiology
All India Institute of Medical Sciences, New Delhi, INDIA Department of Pediatric Surgery, Medical Oncology, and Radiology Clear cell sarcoma of the kidney- rare renal neoplasm second most common renal
More informationRole, timing and technique of radiotherapy in pediatric pleuropulmonary synovial sarcoma
SUPPLEMENT For reprint orders, please contact: reprints@futuremedicine.com Role, timing and technique of radiotherapy in pediatric pleuropulmonary synovial sarcoma Corrado Spatola*,1, Alessandra Tocco
More informationEducational: Desmoid Tumors
17 th March 2011, Berlin Systemic Therapy and PET Imaging Bernd Kasper University of Heidelberg Mannheim University Medical Center ITM - Interdisciplinary Tumor Center Mannheim Sarcoma Unit German Interdisciplinary
More informationThe Prognostic Value of Initial Tumor Size in Patients with Ewing Family of Tumors
Original Article The Prognostic Value of Initial Tumor Size in Patients with Ewing Family of Tumors Rajeeb Kumar Deo 1, Prakash Chitalkar 2, Amit Joshi 1, Sushil Ranamagar 1 1 Department of Medicine, Shree
More informationTumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia
Tumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia Sílvia Bagué Servei de Patologia Hospital de Sant Pau Barcelona Soft tissue sarcomas Heterogeneous group
More informationThe use of larotrectinib in the management of locally advanced pediatric NTRK-fusion sarcoma
The use of larotrectinib in the management of locally advanced pediatric NTRK-fusion sarcoma DuBois SG, 1 Laetsch TW, 2 Federman N, 3 Albert CM, 4 Turpin B, 5 Nagasubramanian R, 6 Reynolds M, 7 Cruickshank
More informationExtraskeletal osteosarcoma of the hand: the role of marginal excision and adjuvant radiation therapy
HAND (2015) 10:602 606 DOI 10.1007/s11552-015-9760-0 REVIEW Extraskeletal osteosarcoma of the hand: the role of marginal excision and adjuvant radiation therapy Dana L. Casey 1 & Matt van de Rijn 2 & Geoffrey
More informationRhabdomyosarcoma is the most common soft-tissue
case report J Neurosurg Pediatr 18:41 45, 2016 Primary pineal rhabdomyosarcoma successfully treated by high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation: case report
More informationNeoadjuvant Treatment of. of Radiotherapy
Neoadjuvant Treatment of Breast Cancer: Role of Radiotherapy Neoadjuvant Chemotherapy Many new questions for radiation oncology? lack of path stage to guide indications should treatment response affect
More informationA CASE OF PRIMARY THYROID LYMPHOMA. Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey
A CASE OF PRIMARY THYROID LYMPHOMA Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey 38 year old female She recognized a mass in her right neck
More informationRadiotherapy in DLCL is often worthwhile. Dr. Joachim Yahalom Memorial Sloan-Kettering, New York
Radiotherapy in DLCL is often worthwhile Dr. Joachim Yahalom Memorial Sloan-Kettering, New York The case for radiotherapy Past: Pre-Rituximab randomized trials Present: R-CHOP as backbone, retrospective
More informationRARE TUMORS OF INFANCY. RAJKUMAR VENKATRAMANI, MD, MS Director, Rare Tumors Program, Texas Children s Hospital
RARE TUMORS OF INFANCY RAJKUMAR VENKATRAMANI, MD, MS Director, Rare Tumors Program, Texas Children s Hospital OBJECTIVES Review the epidemiology and clinical presentation of soft tissue sarcomas in infancy.
More informationRhabdomyosarcoma of the Oral Tissues two new cases and literature review
Rhabdomyosarcoma of the Oral Tissues two new cases and literature review Cristiane Miranda França 1, Eliana M. M. Caran 2, Maria Teresa S. Alves 3, Adriana D. Barreto 4, Nilza N. F. Lopes 5 (1) Oral Pathologist,
More informationSolid Tumour Section Mini Review
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Solid Tumour Section Mini Review Soft tissue tumors: Alveolar rhabdomyosarcoma Frederic G Barr Department
More informationEfficacy of carbon-ion radiotherapy and high-dose chemotherapy for patients with unresectable Ewing s sarcoma family of tumors
DOI 10.1007/s10147-012-0480-y ORIGINAL ARTICLE Efficacy of carbon-ion radiotherapy and high-dose chemotherapy for patients with unresectable Ewing s sarcoma family of tumors Shintaro Iwata Tsukasa Yonemoto
More informationAnalysis of the prognosis of patients with testicular seminoma
ONCOLOGY LETTERS 11: 1361-1366, 2016 Analysis of the prognosis of patients with testicular seminoma WEI DONG 1, WANG GANG 1, MIAOMIAO LIU 2 and HONGZHEN ZHANG 2 1 Department of Urology; 2 Department of
More informationPathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON
Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON Presentation outline Background and epidemiology of sarcomas Sarcoma classification Sarcoma
More informationMusculoskeletal Sarcomas
Musculoskeletal Sarcomas Robert C. Orth, M.D., Ph.D. Edward B. Singleton Department of Pediatric Radiology Texas Children s Hospital Page 0 xxx00.#####.ppt 9/23/2012 9:01:18 AM No disclosures Page 1 xxx00.#####.ppt
More informationPoor-prognostic advanced Germ Cell Tumors
14-10-16 Poor-prognostic advanced Germ Cell Tumors Karim Fizazi, MD, PhD Institut Gustave Roussy, France Metastatic GCT: Prognosis (IGCCC) Good prognosis Intermediate prognosis Poor prognosis J Clin Oncol
More informationRhabdomyosarcoma: The Experience of the Pediatric Unit of
Journal of the Egyptian Nat. Cancer Inst., Vol. 18, No. 1, March: 51-, 6 Rhabdomyosarcoma: The Experience of the Pediatric Unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK)
More informationThe frequency of PAX3 and PAX7 Mutations in Children with Rhabdomyosarcoma
Original Article Iran J Ped Hematol Oncol. 2016, Vol6.No2, 100-105 The frequency of PAX3 and PAX7 Mutations in Children with Rhabdomyosarcoma Farzaneh Jadali MD 1, Kourosh Goudarzi Pour MD 2, Roxana Aghakhani
More informationIntroduction to Pediatric Neoplasms
Introduction to Pediatric Neoplasms F C D S E D U C A T I O N A L W E B C A S T S E R I E S S T E V E N P E A C E, B S, C T R / M A Y R A E S P I N O, B A, R H I T, C T R J A N U A R Y 1 7, 2 0 1 3 1 Program
More informationSpecific Cancer Diagnosis. Age Range France No 149 NR NHL Cancer NA Chemo COPADM
APPENDIX 11: RANDOMIZED CONTROLLED TRIALS OF ANY INTERVENTION FOR THE PREVENTION OF ORAL MUCOSITIS IN PEDIATRIC PATIENTS RECEIVING TREATMENT FOR CANCER OR UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
More information1/15/2013. Introduction to Pediatric Neoplasms. Program Outline. Introduction
Introduction to Pediatric Neoplasms F C D S E D U C A TI O N A L WE B C A S T S E R I E S ST E VE N P E A C E, B S, C T R / MA Y R A E SP I N O, B A, R H I T, C T R J A N U A R Y 1 7, 2 0 1 3 1 Program
More informationCombining Lurbinectedin and Doxorubicin The UCLH Experience in Small Cell Lung Cancer
Combining Lurbinectedin and Doxorubicin The UCLH Experience in Small Cell Lung Cancer Dr Martin Forster MD PhD Clinical Senior Lecturer in Experimental Cancer Medicine Consultant in Medical Oncology UCL
More informationof patients at previously known sites; in three cases new metastatic sites were observed. Patients with primary
Bone Marrow Transplantation, (17) 1, 227 231 17 Stockton Press All rights reserved 0268 336/7 $12.00 Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic
More informationWilms Tumor Outcomes at a Single Institution and Review of Current Management Recommendations
Wilms Tumor Outcomes at a Single Institution and Review of Current Management Recommendations Background: The Duval County Medical Society (DCMS) is proud to provide its members with free continuing medical
More informationpros and cons
A Gynecologic Oncology Group Study Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: v.s. III GOG Marcus E. Randall,
More information<Delete this line and print on hospital headed paper> Euro Ewing 2012
International Randomised Controlled Trial for the Treatment of Newly Diagnosed Ewing's Sarcoma Family of Tumours PARENT INFORMATION SHEET R1 We would
More informationPrimary dumbbell-shaped Ewing's sarcoma of the cervical vertebra in adults: Four case reports and literature review
ONCOLOGY LETTERS 3: 721-725, 2012 Primary dumbbell-shaped Ewing's sarcoma of the cervical vertebra in adults: Four case reports and literature review QING ZHU, JISHENG ZHANG and JIANRU XIAO Department
More informationBuilding the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead
Critical Reviews in Oncology/Hematology 82 (2012) 259 279 Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead J. Carlijn Van Gaal a,b, Eveline S.J.M.
More informationInt J Clin Exp Med 2016;9(6): /ISSN: /IJCEM
Int J Clin Exp Med 2016;9(6):11901-11906 www.ijcem.com /ISSN:1940-5901/IJCEM0020843 Original Article Combined chemotherapy and 125 I-particle implantation for treatment of children with head and neck soft
More informationA Review of Ewing Sarcoma Treatment: Is it Still a Subject of Debate?
Send Orders for Reprints to reprints@benthamscience.ae RESEARCH ARTICLE Reviews on Recent Clinical Trials, 2017, 12, 1-5 1 A Review of Ewing Sarcoma Treatment: Is it Still a Subject of Debate? Wala Ben
More informationRenal tumors are among the most common
Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China Ci Pan, Jiao-Yang Cai, Min Xu, Qi-Dong Ye, Min Zhou, Min-Zhi Yin, Yu-Min Zhong, Jing Chen, Shu-Hong Shen, Jing-Yan
More informationLate Effects in Pediatric Cancer Survivors
Late Effects in Pediatric Cancer Survivors LISA K OPP, DO ASSOCIATE PROFESSOR THE UNIVERSITY OF ARIZONA DEPARTMENT OF PEDIATRICS DIVISION OF HEMATOLOGY/ONCOLOGY/BMT Objectives Review Childhood Cancer and
More informationCOG-ACNS1123: Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Page 1 of 6 COG-ACNS1123: Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT) FAST FACTS Eligibility Reviewed and Verified By
More information14. Background. Sarcoma. Resectable extremity soft tissue sarcomas
96 14. Sarcoma Background Radiotherapy is widely used as an adjunct to surgery in the management of soft tissue sarcomas as the risk of failure in the surgical bed can be high. For bone sarcomas, radiotherapy
More informationSarcomas. Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center
Sarcomas Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center Aaron Sugalski, DO Associate Professor of Pediatric Hematology/Oncology Medical Director, UHS Pediatric Blood and Cancer
More informationREVIEW Children s Oncology Group s 2013 Blueprint for Research: Soft Tissue Sarcomas
Pediatr Blood Cancer 2013;60:1001 1008 REVIEW Children s Oncology Group s 2013 Blueprint for Research: Soft Tissue Sarcomas Douglas S. Hawkins, MD, 1 * Sheri L. Spunt, MD, 2 and Stephen X. Skapek, MD 3
More informationSystemic Treatment. Third International Neuro-Oncology Course. 23 May 2014
Low-Grade Astrocytoma of the CNS: Systemic Treatment Third International Neuro-Oncology Course São Paulo, Brazil 23 May 2014 John de Groot, MD Associate Professor, Neuro-Oncology UT MD Anderson Cancer
More informationBrain Tumors in Children
Brain Tumors in Children Michael A. Grotzer University Children s Hospital of Zurich, Switzerland Incidence of Childhood Cancer CNS Tumors Acute lymphoblastic Leukemia Neuroblastoma Non-Hodgkin Lymphoma
More informationSIRT in the Management of Metastatic Neuroendocrine Tumors
SIRT in the Management of Metastatic Neuroendocrine Tumors Navesh K. Sharma, DO, PhD Assistant Professor, Departments of Radiation Oncology, Diagnostic Radiology and Nuclear Medicine Medical Director,
More informationResearch Article Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience
Sarcoma, Article ID 375151, 6 pages http://dx.doi.org/10.1155/2014/375151 Research Article Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience Henry J. Conter, 1 Vancheswaran
More informationTratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón
Tratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón Santiago Ponce Aix Servicio Oncología Médica Hospital Universitario 12 de Octubre Madrid Stage III: heterogenous disease
More informationA Phase I Dose Escalation Study of Intratumoral Herpes Simplex Virus 1 Mutant rrp450 in Patients with Refractory Sarcoma or Neuroblastoma
A Phase I Dose Escalation Study of Intratumoral Herpes Simplex Virus 1 Mutant rrp450 in Patients with Refractory Sarcoma or Neuroblastoma Timothy P. Cripe, M.D., Ph.D. Associate Professor Division of Hematology/Oncology
More informationThomas Klingebiel und Ewa Koscielniak
Weichteilsarkome bei Kindern und Jugendlichen Stadium IV und Rezidiv - Erfahrungen aus 30 Jahren CWS Studien - Thomas Klingebiel und Ewa Koscielniak Klinik für Kinder- und Jugendmedizin III Theodor Stern
More informationWhat are the hurdles to using cell of origin in classification to treat DLBCL?
What are the hurdles to using cell of origin in classification to treat DLBCL? John P. Leonard, M.D. Richard T. Silver Distinguished Professor of Hematology and Medical Oncology Associate Dean for Clinical
More informationChemotherapy for Cervical Cancer. Matsue City Hospital Junzo Kigawa
Chemotherapy for Cervical Cancer Matsue City Hospital Junzo Kigawa Introduction Worldwide, cervical cancer is the second most common cancer in women and affects 530,000 new patients and 275,000 deaths.
More informationPediatric Soft-Tissue Sarcomas. Beth McCarville, MD St. Jude Children s Research Hospital Memphis, Tn
Pediatric Soft-Tissue Sarcomas Beth McCarville, MD St. Jude Children s Research Hospital Memphis, Tn Overview Histologic classifications Characteristic imaging features Helpful clinical characteristics
More information